| Download a sample from "The Infoshop", another service of Global Information.
|
SUMMARY
The Czech pharmaceutical sector remains one of the better regional prospects
for overseas suppliers, being relatively wealthy and largely reliant on
imported medicines. This report is ideal for executives wanting to understand
the key drivers in the pharmaceutical market and have access to a wealth of
statistical data, including five-year market projections. Included with the
report are 3 free quarterly updated outlook reports, enabling you to keep up
to date with market developments for a year.
Includes 3 quarterly updated outlook reports!
The 1990s were a period of significant change for both the Czech nation and
its healthcare sector. The government has decentralised the health sector
through methods of rationalisation and large scale privatisation, and created
a health system with a diverse mixture of establishments. The introduction of
a health insurance scheme has also played an important part in the development
of Czech healthcare.
The Czech pharmaceutical sector remains one of the better regional prospects
for overseas suppliers, being relatively wealthy and largely reliant on
imported medicines. The international pharmaceutical industry has continued to
challenge the government over its dubious pricing and reimbursement criteria
and IP protection remains an area that needs strengthening. However, much of
the country's regulatory structure has been aligned with EU Directives and
other amendments are expected in the near future. The Czech Republic attained
full EU membership in May 2004.
MARKET OUTLOOK
- Current market size
- Unique 5-year market projections
- Market outlook
- Market structure
- Including statistical data on imports and exports
- Market developments
- Covering recent and impending developments with respect to key issues
such as regulation, health facilities and government policy
- Key national data projections
BACKGROUND DATA
- Population data, including growth trends and age structure
- Demographic indicators detailing principal causes of death and morbidity
HEALTHCARE SYSTEM
- Health expenditure
- Expenditure by source of funding and type
- Hospital services
- Hospital data such as beds by type, region, specialty, patient
admissions, occupancy and surgical procedures
- Outpatient care
- Medical personnel
- Data on healthcare professionals covering such areas as doctors by
specialty, nursing staff and dentists
ACCESSING THE PHARMACEUTICAL MARKET
- Regulatory environment
- Patent protection & intellectual property rights
- Pricing & reimbursement
- Distribution channels
- Domestic production
CONTACT DETAILS
For healthcare organisations and trade associations.
Compelling reasons to buy this Espicom market report
Espicom is a leading provider of market and company information for business.
In addition to this analysis, Espicom provides detailed management reports on
over 60 established and emerging pharmaceutical markets around the world.
- Includes - FREE - three quarterly updated outlook reports on the
Czech pharma market
- Unique and original market forecasts
- Insightful interpretation of market trends and developments
- Fantastic value - no-one else produces such quality data so cost
effectively
- Over 25 years continuous pharmaceutical market experience
- A team of full-time researchers and analysts
- Unbeatable access to primary sources
- Independent and impartial
- Formats to suit every distribution need and budget
TABLE OF CONTENTS
CZECH REPUBLIC: BACKGROUND DATA
GEOGRAPHY
POLITICAL OVERVIEW
ECONOMIC OVERVIEW
- Economic Indicators, 1995-2012
POPULATION
- Population, 1995-2005
- Population by Age Group & Sex, 2005
DEMOGRAPHIC INDICATORS
- Principal Demographic Indicators, 1997-2005
MORTALITY
- Causes of Death, 2005
- Causes of Death, 2001-2004
- Deaths due to Circulatory Disease, 2005
MORBIDITY
- Infectious diseases
- Notified Infectious Diseases, 2001-2005
- New Cases of Cancer Reported in Males, 2005
- New Cases of Cancer Reported in Females, 2005
CHARTS
- Map of the Czech Republic
- Population by Age Group, 2005 (%)
- Leading Causes of Death, 2005 (%)
CZECH REPUBLIC: HEALTHCARE SYSTEM
ORGANISATION & ADMINISTRATION
HEALTH EXPENDITURE
- Public/Private Health Expenditure, 1997-2005
HOSPITAL SERVICES
- Hospital Resources
- Healthcare Facilities and Beds, 2005
- Healthcare Facilities and Beds, 2003-2004
- Hospitals and Beds by Region, 2005
- Hospital Beds by Department, 2001-2005
- Hospital Activity
- Hospital Activity, 1997-2005
- Hospitalisations by Department, 2001-2005
- Hospital Activity by Department, 2003-2005
- Hospital Admissions by Cause, 2005 (ICD 10)
- Transplants & Cardiosurgeries Performed, 1991-2005
- Kidney Dialysis, 1995-2005
- Hospital Equipment
- Selected Installed Equipment in Hospitals, 2005
- Selected Installed Equipment in Hospitals, 1997-2005
AMBULATORY CARE
- Outpatient Facilities, 2001-2005
- Outpatient Examinations in Inpatient & Outpatient Establishments, 2005
- Outpatient Visits, 1998-2004 (000s)
MEDICAL PERSONNEL
- Total Medical Personnel by Type of Employment, 2005 (Whole-Time Equivalent)
- Total Medical Personnel, 2004-2005
- Total Medical Personnel by Region, 2005
- Physicians by Workplace, 2004-2005
- Physicians by Speciality, 2005
CHARTS
- Health Expenditure by Source of Funding, 2005 (%)
- Hospital Beds, 1995-2004
- Hospital Beds, Rate Per Thousand Population, 1995-2005
CZECH REPUBLIC: ACCESSING THE PHARMACEUTICAL MARKET
INTRODUCTION
REGULATORY ENVIRONMENT
- The Medicines Act and the Transposition of EU Directives
- Pharmaceutical Registration/Drug Approval Process
- SUKL Drug Registration Activity, 1999-2004
- Clinical trials
- Post marketing surveillance
- New EU Rules
- Centralised procedure
- Mutual recognition procedure
- Advertising
- Patent Protection & Intellectual Property Rights
- Pricing and Reimbursement
DISTRIBUTION CHANNELS
DOMESTIC PRODUCTION
- GMP Compliance
- API Manufacturers with GMP Certificates, January 2007
- Trade Associations
- MAFS Members, 2007
- CAFF Members, 2007
- Domestic Producers
- Farmak Sales, 2000-2003 (KCs millions)
- ICN Czech Republic (VUAB)
- IVAX CR
- Medicamenta
- Pliva-Lachema
- Spofa
- Zentiva
- Zentiva: Top Brands, 2005 (CZK millions)
- Zentiva Financial Results, 1999-2005
- Pharmaceutical Sales by Region, 2004-2005 (CZK millions)
DIRECTORY
- Government Bodies
- Trade Associations
|
